These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 28521044)
1. Cross-Tissue Exploration of Genetic and Epigenetic Effects on Brain Gray Matter in Schizophrenia. Lin D; Chen J; Ehrlich S; Bustillo JR; Perrone-Bizzozero N; Walton E; Clark VP; Wang YP; Sui J; Du Y; Ho BC; Schulz CS; Calhoun VD; Liu J Schizophr Bull; 2018 Feb; 44(2):443-452. PubMed ID: 28521044 [TBL] [Abstract][Full Text] [Related]
2. Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1. Chen J; Calhoun VD; Lin D; Perrone-Bizzozero NI; Bustillo JR; Pearlson GD; Potkin SG; van Erp TGM; Macciardi F; Ehrlich S; Ho BC; Sponheim SR; Wang L; Stephen JM; Mayer AR; Hanlon FM; Jung RE; Clementz BA; Keshavan MS; Gershon ES; Sweeney JA; Tamminga CA; Andreassen OA; Agartz I; Westlye LT; Sui J; Du Y; Turner JA; Liu J Schizophr Bull; 2019 Jan; 45(1):222-232. PubMed ID: 29474680 [TBL] [Abstract][Full Text] [Related]
3. Voxel-Based Morphometry in Individuals at Genetic High Risk for Schizophrenia and Patients with Schizophrenia during Their First Episode of Psychosis. Chang M; Womer FY; Bai C; Zhou Q; Wei S; Jiang X; Geng H; Zhou Y; Tang Y; Wang F PLoS One; 2016; 11(10):e0163749. PubMed ID: 27723806 [TBL] [Abstract][Full Text] [Related]
4. Guided exploration of genomic risk for gray matter abnormalities in schizophrenia using parallel independent component analysis with reference. Chen J; Calhoun VD; Pearlson GD; Perrone-Bizzozero N; Sui J; Turner JA; Bustillo JR; Ehrlich S; Sponheim SR; Cañive JM; Ho BC; Liu J Neuroimage; 2013 Dec; 83():384-96. PubMed ID: 23727316 [TBL] [Abstract][Full Text] [Related]
5. Association of DNA Methylation Differences With Schizophrenia in an Epigenome-Wide Association Study. Montano C; Taub MA; Jaffe A; Briem E; Feinberg JI; Trygvadottir R; Idrizi A; Runarsson A; Berndsen B; Gur RC; Moore TM; Perry RT; Fugman D; Sabunciyan S; Yolken RH; Hyde TM; Kleinman JE; Sobell JL; Pato CN; Pato MT; Go RC; Nimgaonkar V; Weinberger DR; Braff D; Gur RE; Fallin MD; Feinberg AP JAMA Psychiatry; 2016 May; 73(5):506-14. PubMed ID: 27074206 [TBL] [Abstract][Full Text] [Related]
6. Identification of schizophrenia-associated loci by combining DNA methylation and gene expression data from whole blood. van Eijk KR; de Jong S; Strengman E; Buizer-Voskamp JE; Kahn RS; Boks MP; Horvath S; Ophoff RA Eur J Hum Genet; 2015 Aug; 23(8):1106-10. PubMed ID: 25424713 [TBL] [Abstract][Full Text] [Related]
7. Characterization of cross-tissue genetic-epigenetic effects and their patterns in schizophrenia. Lin D; Chen J; Perrone-Bizzozero N; Bustillo JR; Du Y; Calhoun VD; Liu J Genome Med; 2018 Feb; 10(1):13. PubMed ID: 29482655 [TBL] [Abstract][Full Text] [Related]
8. DNA methylation age is not accelerated in brain or blood of subjects with schizophrenia. McKinney BC; Lin H; Ding Y; Lewis DA; Sweet RA Schizophr Res; 2018 Jun; 196():39-44. PubMed ID: 28988914 [TBL] [Abstract][Full Text] [Related]
9. Toward the identification of peripheral epigenetic biomarkers of schizophrenia. Guidotti A; Auta J; Davis JM; Dong E; Gavin DP; Grayson DR; Sharma RP; Smith RC; Tueting P; Zhubi A J Neurogenet; 2014; 28(1-2):41-52. PubMed ID: 24702539 [TBL] [Abstract][Full Text] [Related]
11. Schizophrenia-associated differential DNA methylation in brain is distributed across the genome and annotated to MAD1L1, a locus at which DNA methylation and transcription phenotypes share genetic variation with schizophrenia risk. McKinney BC; McClain LL; Hensler CM; Wei Y; Klei L; Lewis DA; Devlin B; Wang J; Ding Y; Sweet RA Transl Psychiatry; 2022 Aug; 12(1):340. PubMed ID: 35987687 [TBL] [Abstract][Full Text] [Related]
12. ZNF804A rs1344706 is associated with cortical thickness, surface area, and cortical volume of the unmedicated first episode schizophrenia and healthy controls. Wei Q; Li M; Kang Z; Li L; Diao F; Zhang R; Wang J; Zheng L; Wen X; Zhang J; Zhao J; Huang R Am J Med Genet B Neuropsychiatr Genet; 2015 Jun; 168B(4):265-73. PubMed ID: 25921517 [TBL] [Abstract][Full Text] [Related]
13. DNA methylation analyses of the candidate genes identified by a methylome-wide association study revealed common epigenetic alterations in schizophrenia and bipolar disorder. Sugawara H; Murata Y; Ikegame T; Sawamura R; Shimanaga S; Takeoka Y; Saito T; Ikeda M; Yoshikawa A; Nishimura F; Kawamura Y; Kakiuchi C; Sasaki T; Iwata N; Hashimoto M; Kasai K; Kato T; Bundo M; Iwamoto K Psychiatry Clin Neurosci; 2018 Apr; 72(4):245-254. PubMed ID: 29430824 [TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic regulation on the transcription of GABRB2: Genotype-dependent hydroxymethylation and methylation alterations in schizophrenia. Zong L; Zhou L; Hou Y; Zhang L; Jiang W; Zhang W; Wang L; Luo X; Wang S; Deng C; Peng Z; Li S; Hu J; Zhao H; Zhao C J Psychiatr Res; 2017 May; 88():9-17. PubMed ID: 28063323 [TBL] [Abstract][Full Text] [Related]
15. Associations and Heritability of Auditory Encoding, Gray Matter, and Attention in Schizophrenia. Chen YH; Howell B; Edgar JC; Huang M; Kochunov P; Hunter MA; Wootton C; Lu BY; Bustillo J; Sadek JR; Miller GA; Cañive JM Schizophr Bull; 2019 Jun; 45(4):859-870. PubMed ID: 30099543 [TBL] [Abstract][Full Text] [Related]
16. The association of DNA methylation and brain volume in healthy individuals and schizophrenia patients. Liu J; Siyahhan Julnes P; Chen J; Ehrlich S; Walton E; Calhoun VD Schizophr Res; 2015 Dec; 169(1-3):447-452. PubMed ID: 26381449 [TBL] [Abstract][Full Text] [Related]
17. Cognitive Implications of Correlated Structural Network Changes in Schizophrenia. Jensen DM; Zendrehrouh E; Calhoun V; Turner JA Front Integr Neurosci; 2021; 15():755069. PubMed ID: 35126065 [TBL] [Abstract][Full Text] [Related]
18. Patterns of Gray Matter Abnormalities in Schizophrenia Based on an International Mega-analysis. Gupta CN; Calhoun VD; Rachakonda S; Chen J; Patel V; Liu J; Segall J; Franke B; Zwiers MP; Arias-Vasquez A; Buitelaar J; Fisher SE; Fernandez G; van Erp TG; Potkin S; Ford J; Mathalon D; McEwen S; Lee HJ; Mueller BA; Greve DN; Andreassen O; Agartz I; Gollub RL; Sponheim SR; Ehrlich S; Wang L; Pearlson G; Glahn DC; Sprooten E; Mayer AR; Stephen J; Jung RE; Canive J; Bustillo J; Turner JA Schizophr Bull; 2015 Sep; 41(5):1133-42. PubMed ID: 25548384 [TBL] [Abstract][Full Text] [Related]